Ambrx was founded in 2003 in La Jolla, California.
Ambrx was first incorporated in in 2003 in the state of Delaware and in 2015 became incorporated in the Cayman Islands.
10975 North Torrey Pines Road
La Jolla, California 92037
You can view our Board of Directors by visiting the Board of Directors section of our website.
You can view our management team by visiting the Executive Team section of our website.
December 31st.
Deloitte & Touche LLP.
Ambrx is traded on Nasdaq under the symbol “AMAM".
Shares can be purchased through a stockbroker of your choice.
Ambrx does not offer a direct stock purchase plan.
Currently, Ambrx does not offer a dividend or a dividend reinvestment program.
Annual Reports and other investor materials, when available, can be found in Financials and Filings in the Investor Relations section of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
You can view our recent press releases by visiting the Press Releases section of our website.
For media inquiries please send an email to media@ambrx.com.
You can view information on our development programs by visiting the Pipeline section of our website.
For investor related questions please send an email to ir@ambrx.com.
Please visit the Investor Relations section of our corporate website and fill out our web form to be added to the Ambrx distribution list.
To request additional information, please visit our Contact Us page.